AIM
AIM ImmunoTechยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AIM Profile
Aim Immunotech Inc.
An immuno-pharmaceutical company focused on developing therapies for immune disorders,viruses and cancer diseases
2117 SW Highway 484, Ocala FL
--
AIM ImmunoTech Inc., a specialty pharmaceutical company headquartered in Philadelphia, Pennsylvania, is engaged in the clinical development of new drug therapies based on natural immune system enhancement technologies for the treatment of viral and immune-based chronic diseases. The company was founded in the 1970s and is dedicated to doing research for the National Institutes of Health. Since then, the company has established a strong basic laboratory, preclinical and clinical data related to natural interferons and nucleic acids for improving the body's natural antiviral defense system, and the development of certain adjuvant therapy products for chronic diseases. The company has three domestic subsidiaries-BioPro Corp, BioAegean Corp, and Core BioTech Corp, all of which are registered in Delaware and are dormant. The company's foreign subsidiary is emispherx Biopharma Europe N.V./S.A, which was established in Belgium in 1998 and has the smallest business scope. After the consolidation of the company, all balances and transactions between major subsidiaries have been eliminated.
